Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDXS | Common Stock | Options Exercise | $122K | +35.4K | +3.46% | $3.46 | 1.06M | May 17, 2021 | Direct | F1 |
transaction | CDXS | Common Stock | Sale | -$641K | -35.4K | -3.34% | $18.12* | 1.02M | May 17, 2021 | Direct | F1, F2 |
transaction | CDXS | Common Stock | Options Exercise | $121K | +35K | +3.42% | $3.46 | 1.06M | May 18, 2021 | Direct | F1 |
transaction | CDXS | Common Stock | Sale | -$258K | -13.9K | -1.31% | $18.56* | 1.04M | May 18, 2021 | Direct | F1, F3 |
transaction | CDXS | Common Stock | Sale | -$400K | -21.1K | -2.02% | $18.93* | 1.02M | May 18, 2021 | Direct | F1, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -35.4K | -20.18% | $0.00 | 140K | May 17, 2021 | Common Stock | 35.4K | $3.46 | Direct | F1 |
transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -35K | -25% | $0.00 | 105K | May 18, 2021 | Common Stock | 35K | $3.46 | Direct | F1 |
Id | Content |
---|---|
F1 | Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. |
F2 | This transaction was executed in multiple trades in prices ranging from $17.76 to $18.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F3 | This transaction was executed in multiple trades in prices ranging from $17.80 to $18.79, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F4 | This transaction was executed in multiple trades in prices ranging from $18.80 to $19.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |